Colorectal Surgery Articles & Analysis: Older
26 news found
PARIS, France/Tampa, FL – July, 11, 2022 – SafeHeal™, a leading innovator in the field of digestive surgery and developer of the Colovac device, announced today the appointment of Chris Richardson as Chief Executive Officer (CEO), who assumes responsibilities immediately. ...
BySafeHeal
The CHUV’s Division for Visceral Surgery is at the forefront of establishing a new standard of patient care, and will become a global reference center for hybrid robotic surgery with Dexter. ...
It is one of the most serious complications of colorectal surgery, frequently resulting in the rapid development of severe peritonitis, septic shock, multiple organ dysfunction, and potential mortality. “Participating in a study of this caliber for a potentially groundbreaking advance in the care of colorectal ...
BySafeHeal
Small lesions in the lung are notoriously hard to locate during surgery. With broad application in radio-guided surgery across multiple procedures and major cancer types, SENSEI is currently in use worldwide in prostate, cervical, and colorectal cancer surgery. ...
SafeHeal, a leading innovator in the field of digestive surgery and developer of the Colovac device, announced today a successful 40M€ financing, co-led by Sofinnova Partners and Genesis MedTech Group. ...
BySafeHeal
At Salve Medica, Versius is being used in urology, with plans to expand into general surgery and gynaecology as part of a multispecialty robotics programme. ...
Versius is being used to perform a range of high-volume general surgery and urological procedures, helping to treat patients with colorectal and urological cancers, bowel and kidney disease. ...
Versius has been used to perform a range of surgical specialities including Gynaecology, Colorectal, General and Urology surgeries to date. These include complex cancer cases that would otherwise have had to be performed via open surgical techniques, significantly reducing recovery time for patients and getting them out of hospital sooner. ...
The renowned teaching hospital has adopted the versatile technology in order to increase patient access to minimal access (or keyhole) surgery across both of its London sites. Minimal access surgery is associated with a range of significant patient benefits including reduced recovery time, reduced scarring and reduced pain. ...
The company has a portfolio of products in development based on its patented Microlyte® Matrix technology for tissue engineering to combat local pain and infections in complex wounds such as burns, chronic ulcers, surgical wounds, epidermolysis bullosa, and colorectal surgeries. Research programs at Imbed are partly funded by SBIR grants from National ...
Imbed Biosciences is proud to announce that research conducted using Microlyte Matrix and Microlyte Surgical will be presented in a panel discussion at SAWC, a national wound healing conference. Imbed Biosciences announced today that clinical results documenting the use of its products, Microlyte® Matrix and Microlyte® SURGICAL, will be presented at the Fall Symposium on Advanced Wound ...
Schurr, MD a co-founder of Imbed and Chair of General Surgery at Mountain Area Health Education Center (MAHEC) in Asheville, NC. ...
These improvements, made in cooperation with a growing group of specially trained endoscopists and colorectal surgeons, are influencing the way complex colon polypectomies are performed around the world. ...
The company has a portfolio of products in development based on its patented Microlyte® Matrix technology for tissue engineering to combat local pain and infections in complex wounds such as burns, chronic ulcers, surgical wounds, epidermolysis bullosa, and colorectal surgeries. Research programs at Imbed are partly funded by SBIR grants from National ...
“The DiLumen EIP has the potential to improve or enable less invasive procedures for benign colorectal polyps, and can take the place of open or laparoscopic surgery, thereby preserving anatomy, shortening recovery and reducing healthcare costs,” said Dr. Peter Johann, CEO of Lumendi LTD, who noted that researchers at the University of Florida ...
Françoise Cailler, CEO and Scientific Director of SurgiMab will attend this exciting congress, where world-renowned specialists will gather together during two days to discuss the latest advances in the field of Fluorescence-Guided Surgery. Sessions will cover basic concepts, the use of NIR technology for oncology, colorectal surgery and ...
BySurgiMab
The endolumenal procedure was performed October 1, 2019 by Emre Gorgun, MD, Director of Endolumenal Surgery Center; Lower GI, Colorectal Surgery at The Cleveland Clinic in Cleveland, Ohio. ...
SurgiMab, a late-stage biotechnology company pioneering a new antibody-based fluorescence-guided approach with the aim to improve cancer surgery and clinical outcomes for patients, today announces that the first US patient has been recruited into its on-going pivotal Phase 3 clinical trial evaluating its investigational imaging agent SGM-101 in patients undergoing ...
BySurgiMab
Colovac is a unique endoluminal bypass sheath placed in the colon following colorectal resection. It suppresses the contact of fecal content with the colorectal anastomotic site in order to significantly improve patient recovery after colorectal surgery, without the need for an ostomy. ...
BySafeHeal
Jan 11, 2019 –SafeHeal, an innovator in the field of digestive surgery, has concluded its first-in-human clinical study for its novel Colovac bypass sheath in patients undergoing colorectal surgery. ...
BySafeHeal